Patient Education in Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease Clinical Trial

Official title:

Patient Education in Gastroesophageal Reflux Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00618150
• Other study ID #: Sak 33-96 (REK)
• Secondary ID: SLKNR 96/00515
• Status: Completed
• Phase: N/A
• First received: February 5, 2008
• Last updated: January 16, 2017
• Start date: September 1996

Study information

• Verified date: January 2017
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients with gastroesophageal reflux disease (heart-burn, acid regurgitation)may benefit from an educational program explaining the medical aspects of the disease, self-management strategies and how to deal with health services. We hypothesized that patients having participated in an educational program would experience an improved quality of life when compared to patients who did not take part (controls).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 211
• Est. primary completion date: December 1999
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 75 Years

Eligibility

Inclusion Criteria:

• heartburn and acid regurgitation the dominant symptom

• needing relief at least 5 days/ week when symptoms were at their worst

• disease history at least 3 months

• ability to give informed consent

Exclusion Criteria:

• current or previous esophagitis stage 2(Savary-Miller) or greater or peptic ulc

• continuous need of proton pump inhibitors or NSAIDs

• wish for surgical treatment

• earlier surgical treatment in the GI-tract

• pregnancy

• alcohol or drug abuse

Related Conditions & MeSH terms

• Gastroesophageal Reflux
• Gastroesophageal Reflux Disease

Intervention

Behavioral:
• Patient education
An educational program: Three lessons spaced over 2 weeks.

Locations

Country	Name	City	State
Norway	Norwegian University of Science and Technology, Med. fac.	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology	Norwegian Foundation for Health and Rehabilitation

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Urnes J, Farup PG, Lydersen S, Petersen H. Patient education in gastro-oesophageal reflux disease: a randomized controlled trial. Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1104-10. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life		one year